Digistain (Seed)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$12,000,000
Company Info
Founders
Hemmel Amrania
Market
Healthcare & Wellness
Coinvestors
Y Combinator
Company Description

Developer of medical imaging platform intended to eliminate the overuse of cancer chemotherapy with a quick and affordable diagnostic test. Digistain uses infrared scanning to determine which breast cancer patients are fit for chemotherapy.